Pasithea Therapeutics (KTTA) Other Working Capital Changes (2022 - 2024)
Pasithea Therapeutics (KTTA) posted Other Working Capital Changes of $12647.0 for Q1 2026, down 96.66% sequentially from $379158.0 in Q4 2025, and down 35.17% YoY from $19509.0 in Q1 2025.
Pasithea Therapeutics (KTTA) Other Working Capital Changes (2022 - 2024) Analysis & Trends
Pasithea Therapeutics has reported Other Working Capital Changes for 5 years, with the latest figure at $12647.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 35.17% year-over-year to $12647.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $262416.0 (up 1416.42% YoY) and the FY2025 annual result came in at $269278.0, up 12004.42% from the prior year.
- Other Working Capital Changes rose to -$963.0 in Q2 2024 per KTTA's latest filing, from -$1446.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $574684.0 in Q3 2022 and troughed at -$358287.0 in Q4 2022.
- A 5-year average of $11428.6 and a median of -$1804.0 in 2023 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 33736.21% in 2025, down 1241.2% in 2025.
- Over 2 years, Other Working Capital Changes stood at $561520.0 in 2022, then slumped by 100.17% to -$963.0 in 2024.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$963.0, -$1446.0, and $561520.0 for Q2 2024, Q1 2024, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pasithea Therapeutics | 16.97 Mn | 16.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -963.00 |
| Jun 30, 2024 | -963.00 |
| Jun 30, 2024 | -963.00 |
| Mar 31, 2024 | -1,446.00 |
| Mar 31, 2024 | -1,446.00 |
| Mar 31, 2024 | -1,446.00 |
| Dec 31, 2022 | 561,520.00 |
| Dec 31, 2022 | 561,520.00 |
| Dec 31, 2022 | 561,520.00 |
| Sep 30, 2022 | -48,914.00 |
| Sep 30, 2022 | -48,914.00 |
| Sep 30, 2022 | -48,914.00 |